Ihuarraqax123 Posted - 9 hours ago

$Bctx they started buying. let's see what effect it will have on the share price

Doctorstocs Posted - 11 hours ago

$BCTX https://fintel.io/sob/us/bctx

GoodGodly Posted - 15 hours ago

$BCTX CVI bought 2.5 million shares early Sep then CVI sold 1.9 million shares on Sep 30 The company announced offering on Oct 01 causing SP to plummet how the fuck in this world, CVI came to know about the offering before it was announced?

stocksareneato Posted - 16 hours ago

$BCTX well, nothing new around here unfortunately. What sounds like good news every time either no rise or a sharp decline. Nevertheless me and my 10,000 shares will be here chilling and either going to $20 or $0. Cheers dudes.

Fvalstounge Posted - 17 hours ago

$BCTX I came to ST almost 3-1/2 years ago, because there was no where else to discuss BCTX with like-minded investors. I really wanted to find those who had information or due-diligence to share and who could help me learn about the science behind these novel therapies. Certainly, it's been quite the learning experience, and I've enjoyed sharing and growing with everyone here. I feel it's time to expand a bit and move beyond the confines of this platform. There is still value in this community, but I seek a greater focus on the science of cancer treatments in general, not just the share price of BCTX. To that end, I've launched my free Discord, Big Thompson Biotech. A place to share and discuss research and due-diligence into the details of various therapies and approaches. It's not a replacement for other platforms (like ST). Rather, it is an additional resource for interested parties. We will begin building our community next week. PM me with your Discord username for an invite.

Noswimming Posted - 22 hours ago

@Fvalstounge @GoodGodly It is unfortunate as it's a sign of the months to come. I would love to hang in and support Briacell, but without an institutional pharmaceutical as a partner, they'll continue to be manipulated to mere pennies. As we get closer to the inauguration, I fear there will be less of a chance for big pharma to jump on board. It's so damn frustrating to see acquisition after acquisition happening, but there's no love for BRIA-IMT/OTS. I can only think that negotiations are taking place, which would explain the radio silence regarding the investment side of $BCTX. I'll hang here till after the 1st of the year, but will begin planning an exit strategy if this don't turn around.

GoodGodly Posted - 1 day ago

$BCTX As per latest filing, an institution bought shares of the company. Go and check their sec filing latest report. Institution are already buying and retailers are always late in the party!! I wonder why? lol..

made006 Posted - 1 day ago

$BCTX seem like Wallstreet doesn't like cancer vaccine , what happened to BCTX also happened to $IOBT which also treat a blockbuster melanoma and lung cancer . Big pharma acquisition mainly in radiotherapy and ADC

Rybod30 Posted - 1 day ago

$BCTX Going down with the ship on this one☹️🏴‍☠️🐬🌊🍺

rmbadd Posted - 1 day ago

$BCTX certainly watching for .40s again. I traded this for a decent profit in 2021, was trading at 10.00 DOLLARS

Noswimming Posted - 1 day ago

@FredFlintstock I would tend to agree with you, but mgt hasn't been hiding any of the data, which tends to be the case when the data doesn't support the hype. I would imagine if they're in discussions, $BCTX is seeking a valuation that is too high for a drug that doesn't yet have full FDA approval. A full approval of IMT and OTS would likely yield above a $7B valuation, and that's pretty steep for any company to pay. Having worked on this for 20+ years, I can't imagine the CEO isn't going to sell for any less than he feels it's worth. Someone will have to give in this scenario.

Noswimming Posted - 1 day ago

@Hannibal_Smith It really is baffling, especially since a trial with Keytuda and BRIA-IMT has already been run and it showed improved results for Keytruda. That being said, they didn't continue the trial, so there could be something behind that. Possibly a falling out with mgt or $BCTX may be seeking an outrageous valuation.

Noswimming Posted - 1 day ago

@Hannibal_Smith Our best hope is that they've been working on a deal, but haven't reached a price agreement. If they have been working on a BO, the nomination of RFK will likely force the hand of whatever big pharma/s is/are at the table to concede on price. Keep in mind a BO not only secures BRIA-IMT, but it also likely comes with the pipeline for $BCTX. I would guess if $BCTX is selling IMT and their pipeline, they'd be asking above $5B.

Hannibal_Smith Posted - 1 day ago

$BCTX Some more info on 'the war on PD-1' between Summit and Merck. Is it me, or is the BRIA platform much more interesting than inhibiting the formation of new bloodcells??? The drugs from LaNova and Summit Therapeutics work by simultaneously blocking proteins called PD-1 and VEGF. Cancer cells often hide behind PD-1 proteins. Blocking it allows the immune system to find and kill cancer cells. Inhibiting VEGF prevents the formation of new blood cells, cutting off the cancer's blood supply. Keytruda, on the other hand, works by blocking PD-1 alone

Noswimming Posted - 1 day ago

$BCTX I just don't see how $BCTX doesn't secure a deal. Many of these companies are being bought out during phase 1 trials. https://finance.yahoo.com/news/merck-facing-threat-keytruda-buys-103900275.html

Hannibal_Smith Posted - 1 day ago

$BCTX Summit Therapeutics, the company who hold the rights for the drug that is outperforming Keytruda in late stage trials, has a market cap of 18 billion dollars. BCTX has a drug, outperforming Keytruda, in late stage trial, and has a market cap of 20 million dollars. This doesn't make any sense

Hannibal_Smith Posted - 1 day ago

$BCTX Merck is just buying all competitors of their Keytruda drug, that are outperforming Keytruda in late stage trials. Isn't that exactly what BRIA-IMT is doing? LETSGO Merck. Keytruda sales are 25 billion annualy. We will agree a buy out at 5 billion, deal? Nov 14 (Reuters) - Merck (MRK.N), opens new tab has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3 billion deal, two months after a similar therapy from Summit Therapeutics outperformed its blockbuster Keytruda in a late-stage trial in the country. The deal allows Merck to take over development of privately held LaNova Medicines' LM-299, the companies said on Thursday.

Noswimming Posted - 1 day ago

@Judy11 Damn straight. If $BCTX doesn't have a partnership or BO inked before RFK is confirmed, we can all say goodbye to our money.

Judy11 Posted - 1 day ago

$BCTX fml

JJBurch Posted - 1 day ago

$BCTX all the drug companies getting obliterated thanks to the RFK pick

JJBurch Posted - 2 days ago

$BCTX Why I keep accumulating as much as I can every day. Every single day

GoodGodly Posted - 2 days ago

$BCTX Reasons to buy now : 1. Late stage cancer drug (ph-3)-IMT with impressive phase-2 results 2. A great cancer vaccine in the early stage of development - OTS 3. Insiders buying (May-2014, an insider made a purchase of $2.5 million worth of shares and CEO is taking a good portion of his salary in shares) 4. Market Cap is just 20 mn for a company that has success probability of 73% of having a drug with TAM in excess of 10s of billions in the next 1-2 years. 5. Downside - $0.45 Upside- $25 Awesome risk-reward

Hannibal_Smith Posted - 2 days ago

$BCTX VERY interesting

sjaak38 Posted - 2 days ago

$BCTX

Noswimming Posted - 2 days ago

@Hannibal_Smith You're spot on. Even though they may not have continued testing with Keytruda, it doesn't mean that $MRK wouldn't find benefit in licensing BRIA-IMT, or possibly buying $BCTX for their pipeline.

Noswimming Posted - 2 days ago

@Hannibal_Smith I had previously talked with Jeff about the testing with Keytruda, cause I read they ended that test. He confirmed that although the combination of Keytruda and BRIA-IMT showed improved results, they were no longer testing together, but they had moved on to testing with a similar product from $INCY. I could see a licensing deal struck with $INCY. It wouldn't be as lucrative as a deal with Merck, but I'm confident it would launch $BCTX into the $20s.

Hannibal_Smith Posted - 2 days ago

$BCTX I will keep saying it. Merck is buying similar therapies to their Keytruda drug… we are allready working with Keytruda if I am not mistaken.. We have a phase 3 ongoing For BRIA-OTS we have a phase 3 design allready. This is ready for a buy out. More than ready.

Hannibal_Smith Posted - 2 days ago

$BCTX Good find buddy! Merck is searching for deals and similar therapies to Keytruda (which will lose it’s exclusivity)

Butbutbut Posted - 2 days ago

$BCTX what I meant in my previous post is. A potential change in philosophy at the FDA. Safe means go. That is all. BCTX has triple life expectancy with no adverse effects.

Noswimming Posted - 2 days ago

@Butbutbut Without big pharma to manufacture, market, and cell BRIA-IMT or BRIA-OTS; Briacell is going to need hundreds of millions of dollars to create the manufacturing system to produce the drug. They're going to have to spend millions creating a market and sales team. In order to do this without big pharma, Briacell is going to have to dilute to the tune of 200M+. Even if they're able to partner with a small pharmaceutical, they're still going to need way more cash than they have on hand. Dude, you are so clueless on how a R&D company gets their drug to market. If you ever hope to see a profit, assuming you're not shorting $BCTX, RFK Jr. is our enemy.